Asthma/COPD:
Indications for Ipratropium Bromide Inhalation Solution:
Bronchospasm associated with chronic bronchitis and emphysema.
Adult Dosage:
500mcg orally by nebulization 3–4 times daily; separate doses by 6–8 hours.
Children Dosage:
Not established.
Ipratropium Bromide Inhalation Solution Contraindications:
Allergy to atropine or its derivatives.
Ipratropium Bromide Inhalation Solution Warnings/Precautions:
Not for primary treatment of acute attack. Avoid eyes. Narrow-angle glaucoma. GU obstruction. Pregnancy. Nursing mothers.
See Also:
Ipratropium Bromide Inhalation Solution Classification:
Anticholinergic.
Ipratropium Bromide Inhalation Solution Interactions:
Caution with other anticholinergics.
Adverse Reactions:
Bronchitis, COPD exacerbation, dyspnea, headache, anticholinergic effects; paradoxical bronchospasm, hypersensitivity reactions.
Generic Drug Availability:
HFA (NO); soln (YES)
How Supplied:
Inhaler—12.9g (200 inh); inhalation soln—contact supplier
